IGC Pharma, Inc. (IGC)
0.3019
0.00 (0.00%)
USD |
NYAM |
Apr 10, 16:00
0.30
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma EPS Diluted (Quarterly) : -0.0076 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| electroCore, Inc. | -0.3792 |
| Lantern Pharma, Inc. | -0.362 |
| 4D Molecular Therapeutics, Inc. | 0.3367 |
| NRX Pharmaceuticals, Inc. | 0.0113 |
| Acurx Pharmaceuticals, Inc. | -0.6722 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.726M |
| Revenue (Quarterly) | 0.35M |
| Total Expenses (Quarterly) | 1.076M |
| Enterprise Value | 29.03M |
| Gross Profit Margin (Quarterly) | -1.71% |
| Profit Margin (Quarterly) | -207.4% |
| Earnings Yield | -20.47% |
| Normalized Earnings Yield | -25.60 |